MENU
+Compare
BDSX
Stock ticker: NASDAQ
AS OF
Jul 1, 04:59 PM (EDT)
Price
$0.29
Change
+$0.01 (+3.57%)
Capitalization
140.57M

BDSX Biodesix Forecast, Technical & Fundamental Analysis

Biodesix Inc is a diagnostic solutions company with a focus in lung disease... Show more

BDSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BDSX with price predictions
Jun 30, 2025

BDSX sees its Stochastic Oscillator ascends from oversold territory

On June 30, 2025, the Stochastic Oscillator for BDSX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 57 instances where the indicator left the oversold zone. In of the 57 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BDSX advanced for three days, in of 209 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BDSX as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDSX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BDSX entered a downward trend on June 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (30.675) is normal, around the industry mean (24.307). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.425) is also within normal values, averaging (42.612).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BDSX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDSX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BDSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BDSX is expected to report earnings to fall 12.87% to -6 cents per share on August 12

Biodesix BDSX Stock Earnings Reports
Q2'25
Est.
$-0.07
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.01
Q3'24
Est.
$-0.07
Q2'24
Beat
by $0.01
The last earnings report on May 13 showed earnings per share of -7 cents, missing the estimate of -7 cents. With 1.43M shares outstanding, the current market capitalization sits at 140.57M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
919 West Dillon Road
Phone
+1 303 417-0500
Employees
217
Web
https://www.biodesix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BPAIX32.49N/A
N/A
Boston Partners All Cap Value Instl
HQIFX20.70N/A
N/A
Hartford Equity Income F
GGHPX7.98N/A
N/A
Goldman Sachs Intl Eq Div & Prem P
CNPSX66.12N/A
N/A
Consumer Staples UltraSector ProFund Svc
MNHRX26.49N/A
N/A
Manning & Napier Pro-Blend Max Term R

BDSX and Stocks

Correlation & Price change

A.I.dvisor tells us that BDSX and ELMD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDSX and ELMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDSX
1D Price
Change %
BDSX100%
+12.74%
ELMD - BDSX
30%
Poorly correlated
N/A
KSRBF - BDSX
26%
Poorly correlated
N/A
RVTY - BDSX
26%
Poorly correlated
-1.12%
ICAD - BDSX
24%
Poorly correlated
-0.52%
PLSE - BDSX
24%
Poorly correlated
+0.07%
More